About this trial
The purpose of this study is to construct a cohort for the hydatidiform mole.
Eligibility criteria
Qualifiers
Patients who are diagnosed with hydatidiform mole (including: complete hydatidiform mole/partial hydatidiform mole; one of twins with hydatidiform mole; ectopic pregnancy hydatidiform mole; macroscopic or microscopic hydatidiform changes indicating early complete or partial hydatidiform mole can not be excluded; atypical placental site nodule) for the first time;
Age 13-55 years old;
Obtain informed consent and sign an informed consent form
Disqualifiers
Patients who are unable to cooperate with the investigation such as mental disorders or cognitive impairment
No histopathology diagnosis;
Patients with other malignancies
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
Locations
Sponsors and collaborators
Women's Hospital School Of Medicine Zhejiang University
Lead sponsor